You are here: Industry Insights > Merck

News List

EMA validates Merck’s application to review tepotinib for lung cancer pharmaceutical-technology
November 30, 2020
The European Medicines Agency (EMA) has validated Merck’s application for reviewing tepotinib as a treatment for adult patients with advanced non-small cell lung cancer (NSCLC) harbouring mesenchymal-epithelial transition factor gene (MET) exon 14 ...
European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations prnasia
November 27, 2020
Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) ...
Merck agrees to buy biopharma firm OncoImmune for $425m pharmaceutical-technology
November 25, 2020
Merck (MSD) has signed a definitive agreement to acquire all outstanding shares of clinical-stage biopharmaceutical firm OncoImmune through a subsidiary, for an upfront payment of $425m in cash.
Agenus Announces Milestone Payment from Merck americanpharmaceuticalreview
November 23, 2020
Agenus announced that a milestone payment of $10M from Merck has been triggered with the advancement of an ILT4 antibody, MK-4830, into a Phase 2 clinical trial.
Cue Biopharma, Merck Extend Biologics Research Alliance contractpharma
November 20, 2020
To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.
FDA approves Merck’s Keytruda with chemotherapy to treat breast cancer pharmaceutical-technology
November 17, 2020
Merck (MSD) has secured approval from the US Food and Drug Administration (FDA) for its Keytruda in combination with chemotherapy for treating patients with locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC) whose tumours ..
Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific prnasia
November 11, 2020
Singapore-based Holmusk announced a collaboration with the Healthcare business sector of Merck, a leading science and technology company to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes.
Merck to acquire oncology firm VelosBio for $2.75bn pharmaceutical-technology
November 09, 2020
Merck (MSD) has signed a definitive agreement to acquire all outstanding shares of Pappas Capital’s portfolio company VelosBio through a subsidiary for $2.75bn in cash, subject to certain customary adjustments.
EC approves AstraZeneca and Merck’s Lynparza for two cancer types pharmaceutical-technology
November 06, 2020
AstraZeneca and Merck’s (MSD) Lynparza (olaparib) has secured approval from the European Commission for prostate cancer and ovarian cancer treatments in the European Union (EU).
Financial Report：Merck contractpharma
November 06, 2020
Pharmaceutical sales were up 2% to $11.3 billion in the quarter, driven primarily by growth in oncology and certain hospital acute care products.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page